Reference
Voruz S, et al. Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine. Experimental Hematology and Oncology 10: No. 1, 2021. Available from: URL: http://www.ehoonline.org/
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1884, 49 (2021). https://doi.org/10.1007/s40278-021-06370-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-06370-4